Visual storyteller Taiwo Aina Adeokun spent several months traveling across Nigeria in 2025-2026,…

Italy’s Angelini Pharma has set its sights on the lucrative U.S. market, buying rare disease…

A survey of more than 7,000 people in Australia, the UK and the US found…

When Optimi Health launched its 2.5 million-share initial public offering (IPO) last month (PDF), the…

Following the surprise rejection in early 2026, the FDA agreed to reconsider the T-cell therapy…

In this interview, news medical talk to Dr. Katie BarberAbout , Clinical Director, General Practitioner,…

Recent research published in journals Personality and Social Psychology Bulletin Evidence shows that how single…

GLP-1 drugs such as Ozempic have transformed treatment for many people with type 2 diabetes…

Medicare Advantage now covers more than half of beneficiaries, but federal enforcement, mostly with relatively…

While GLP-1 drugs are revolutionizing obesity treatment, new research reveals a surprising reality. People can…